Hugel Investor Relations Material

Hugel Inc is a South Korea-based biopharmaceutical company specializing in aesthetic and therapeutic medical products. The company develops, manufactures, and markets botulinum toxin products, dermal fillers, and other medical devices used in cosmetic procedures and treatments. Hugel also provides related services for aesthetic clinics and healthcare providers. Its operations include research and development, regulatory compliance, and international distribution, serving both domestic and overseas markets. The company is headquartered in Gangwon-do, South Korea, and its shares are listed on the KRX.